Aurinia Pharmaceuticals CEO Peter Greenleaf's 2021 pay falls 88% to $1.2M
Aurinia Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 18, 2022
Aurinia Pharmaceuticals reported fiscal year 2021 executive compensation information on April 18, 2022.
In 2021, five executives at Aurinia Pharmaceuticals received on average a compensation package of $823K, a 82% decrease compared to previous year.
Average pay of disclosed executives at Aurinia Pharmaceuticals
Peter Greenleaf, Chief Executive Officer, received $1.2M in total, which decreased by 88% compared to 2020. 58% of Greenleaf's compensation, or $724K, was in salary. Greenleaf also received $507K in non-equity incentive plan and $9.8K in other compensation.
For fiscal year 2021, the median employee pay was $255,489 at Aurinia Pharmaceuticals. Therefore, the ratio of Peter Greenleaf's pay to the median employee pay was 5 to one.
Max Donley, EVP, Operations and Strategy, received a compensation package of $730K, which decreased by 78% compared to previous year. 61% of the compensation package, or $449K, was in salary.
Stephen Robertson, General Counsel, earned $722K in 2021, a 80% decrease compared to previous year.
Joe Miller, Chief Financial Officer, received $710K in 2021, which decreases by 81% compared to 2020.
Max Colao, Chief Commercial Officer, earned $710K in 2021, a 85% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 18, 2022.